These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 14612923

  • 1. In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression.
    Miracco C, De Santi MM, Luzi P, Lalinga AV, Laurini L, De Nisi MC, Angeloni G, Brogi M, Cardone C, Carducci A, Arcuri F, Tosi P, Rubino G, Pirtoli L.
    Int J Oncol; 2003 Dec; 23(6):1529-35. PubMed ID: 14612923
    [Abstract] [Full Text] [Related]

  • 2. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
    Harada K, Kurisu K, Tahara H, Tahara E, Ide T, Tahara E.
    J Neurosurg; 2000 Oct; 93(4):618-25. PubMed ID: 11014540
    [Abstract] [Full Text] [Related]

  • 3. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.
    Miracco C, Margherita De Santi M, Schürfeld K, Santopietro R, Lalinga AV, Fimiani M, Biagioli M, Brogi M, De Felice C, Luzi P, Andreassi L.
    Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas.
    Taniguchi K, Wakabayashi T, Yoshida T, Mizuno M, Yoshikawa K, Kikuchi A, Nakashima N, Yoshida J.
    J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824
    [Abstract] [Full Text] [Related]

  • 6. [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
    Chi YK, Shen Q, Wang JC, Zheng XZ, Hou L, Zhang B.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug 18; 40(4):363-8. PubMed ID: 18677381
    [Abstract] [Full Text] [Related]

  • 7. Pediatric glioblastomas: a histopathological and molecular genetic study.
    Suri V, Das P, Pathak P, Jain A, Sharma MC, Borkar SA, Suri A, Gupta D, Sarkar C.
    Neuro Oncol; 2009 Jun 18; 11(3):274-80. PubMed ID: 18981259
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients.
    Ganigi PM, Santosh V, Anandh B, Chandramouli BA, Sastry Kolluri VR.
    Pediatr Neurosurg; 2005 Jun 18; 41(6):292-9. PubMed ID: 16293948
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF, Miller DC, Koslow M, Newcomb EW.
    J Neurosurg; 1994 Sep 18; 81(3):427-36. PubMed ID: 8057151
    [Abstract] [Full Text] [Related]

  • 12. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
    Ludwig HC, Feiz-Erfan I, Bockermann V, Behnke-Mursch J, Schallock K, Markakis E.
    Anticancer Res; 2000 Sep 18; 20(1A):299-304. PubMed ID: 10769671
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma.
    Kim B, Myung JK, Seo JH, Park CK, Paek SH, Kim DG, Jung HW, Park SH.
    J Neurol Sci; 2010 Jul 15; 294(1-2):112-8. PubMed ID: 20441994
    [Abstract] [Full Text] [Related]

  • 18. Expression of p53 and selected proliferative markers (Ki-67, MCM3, PCNA, and topoisomerase IIα) in borderline ovarian tumors: Correlation with clinicopathological features.
    Ciepliński K, Jóźwik M, Semczuk-Sikora A, Gogacz M, Lewkowicz D, Ignatov A, Semczuk A.
    Histol Histopathol; 2018 Feb 15; 33(2):171-179. PubMed ID: 28493257
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Age-related expression of p53, Mdm2, EGFR and Msh2 in glioblastoma multiforme.
    Stark AM, Hugo HH, Witzel P, Mihajlovic Z, Mehdorn HM.
    Zentralbl Neurochir; 2003 Feb 15; 64(1):30-6. PubMed ID: 12582944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.